|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
SCAI.org Editors Discuss Key Structural and Valvular Takeaways From ACC.15
Looking for a go-to online resource for structural and valvular interventions? Then be sure to check out the all-new SCAI.org Structural and Valvular Section. There, you'll find section editors Kreton Mavromatis, MD, FSCAI, and George Hanzel, MD, FSCAI, discussing the key takeaways from ACC.15 — journal scans reviewing the latest literature in the field and image reviews, including the use of a Watchman device by Sameer Gafoor, MD. Visit and bookmark the site now.
| Share this article:
New Expert Consensus Statement Provides Recommendations to Guide Minimally Invasive Valve Treatments for Children and Adults
As congenital heart disease treatment advances, children with these conditions are living into adulthood, and over time, they may need additional treatment. A new expert consensus paper released today by the Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American College of Cardiology and The Society of Thoracic Surgeons provides guidance on transcatheter pulmonic valve replacement, or tPVR, for children and adults who were previously treated for CHD.
Related: Guidelines Outline Criteria for Transcatheter Pulmonic Valve Replacement (Cardiovascular Business)
Catheter-Based Pulmonary Valve Recs Stress Heart Team (MedPage Today)
Don't Forget! Discounted SCAI 2015 Tuition and Hotel Rates End Friday
Don't miss Interventional Cardiology's Meeting: SCAI 2015 in San Diego May 6-9. Make your plans this week and save. Both the advance tuition and hotel discount rates end at midnight on Friday. Society members that enroll for SCAI 2015 by Friday will save up to $550 off the nonmember, on-site tuition. Register now.
More good news: SCAI has arranged a terrific room rate at the Hilton Bayfront starting at $215 (plus taxes and fees) through Friday or until the SCAI room block sells out. Be sure to make your room reservations now.
Has Your Cath Lab Team Joined the SCAI Team?
It takes a team to achieve success in the cath lab. It takes a team to advance interventional cardiology. Recognizing that engaging the whole cath lab team in advancing our profession is just as important as it is in achieving successful patient outcomes in our labs, SCAI has opened its membership to the entire cath lab team! Join the SCAI team today as a cardiovascular professional (CVP) member and automatically save $200 on tuition for SCAI 2015 Scientific Sessions. Learn more about CVP member benefits and join today!
RSVP Now for Pediatric SCAI-QIT Webinar Series Finale April 7
SCAI is encouraging all pediatric interventionalists and their cath lab teams to participate in the finale of the Pediatric SCAI Quality Improvement Toolkit (SCAI-QIT) Webinar Series on Radiation Safety on Wednesday, April 7 at 1 p.m. EDT.
Ralf J. Holzer, MD, FSCAI, will highlight the importance and implication of radiation exposure for the pediatric population. The webinar will cover radiation physics and biological effects of radiation exposure, while also providing examples of how to reduce radiation exposure to patients and staff as well as new technological advances that help reduce radiation exposure. RSVP for free.
Image of the Week
This is not your traditional surgical or transcatheter heart valve. Chad Kliger, MD, reviews the use of a sutureless, rapid deployment aortic valve in a patient with a history of severe aortic stenosis.
Abiomed's Impella 2.5 Wins PMA Approval
Medical Device and Diagnostics Industry
Impella 2.5, the main product for Abiomed Inc., has received Food and Drug Administration premarket approval for use in elective and urgent high-risk percutaneous coronary intervention procedures. The device, which has had 510(k) clearance since 2008, was evaluated for a PMA under FDA's 515 initiative.
President's Message: Major Strides for Our Higher-risk Patients (SCAI)
One-third of Heart Attack Patients Don't Remember They Had a Heart Attack
A heart attack is generally a massive medical event, when blood stops flowing to the heart. It's often a terrifying experience — the rushed trip to the hospital, the risk to one's life — that can sometimes lead to post-traumatic distress disorder.
Drug-coated Balloons Expand Treatment Options
After years of development and use in other parts of the world, the first drug-coated balloons for the treatment of lower-extremity peripheral artery disease approved in the United States have heralded great enthusiasm. The Food and Drug Administration announced approval of the Lutonix 035 Drug-Coated Balloon PTA Catheter in October and the IN.PACT Admiral Drug-Coated Balloon in January.
SCAI Leads Multi-society Effort in Support of Patient Access to Drug-coated Balloons (SCAI)
Research Suggests Genetic Predisposition to Spontaneous Coronary Artery Disease
Mayo Clinic via News-Medical.Net
A Mayo Clinic study has identified a familial association in spontaneous coronary artery dissection, a type of vascular disease that most commonly affects younger women, suggesting a genetic predisposition to the condition, researchers say. The results are published in the March 23 issue of JAMA Internal Medicine.
Revised Guidelines Released for Pediatric Cardiology Fellowship
HealthDay News via Doctors Lounge
The Society of Pediatric Cardiology Training Program Directors have developed the 2015 Training Guidelines for Pediatric Cardiology Fellowship Program together with the American College of Cardiology, the American Academy of Pediatrics and the American Heart Association. According to a news release issued by the American College of Cardiology, 63 authors worked on the introduction and eight task force reports that make up the guidelines, which are a revision of the 2005 guidelines.
How Will PROMISE Change Practice for Angina Dx?
The PROMISE trial showed overall similarity in outcomes between CT angiography and noninvasive functional testing for stable angina, so what effect will it have on practice?
Experts at the American College of Cardiology conference in San Diego where the findings were presented suggested a complex picture of both dampened enthusiasm for CTA and an increased evidence base that could actually increase its use.
PCI as Good as CABG for Left Main CAD: 5-year PRECOMBAT Data
Five years after patients with left main coronary stenosis either underwent PCI with a sirolimus-eluting stent or had CABG, there was no difference in major adverse cardiac or cerebrovascular events in the two groups, in the Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease trial. There was no between-group difference in the primary end point of MACCE (a composite of death from any cause, MI, stroke or ischemia-driven target vessel revascularization), or in rates of death, MI or stroke.
Demand Wanes for Higher-cost Angiography Systems
The average cost of angiography systems dropped 25 percent in January 2015 compared with the same month last year, as buyers showed less interest in purchasing higher-end systems, according to the Modern Healthcare/ECRI Institute Technology Price Index.
The average cost of the systems was $973,353 in January.
For a complete list of job postings, click here
To post your resume, click here
The news summaries appearing in SCAI This Week are based on original information from news organizations and are produced by Multibriefs, an independent e-mail newsletter publisher. SCAI is not responsible for the content of sites external to SCAI, nor do reports in SCAI This Week constitute the official opinion of SCAI.
The SCAI This Week news roundup is provided as a timely update for SCAI members and other healthcare professionals. Links to articles are provided for readers' convenience and may be of use in discussions with patients or colleagues. Questions and comments about SCAI This Week may be directed to Multibriefs at email@example.com.
Missed last week's issue? See which articles your colleagues read most.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063